Australia markets open in 8 hours 35 minutes

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6621-0.0200 (-2.93%)
At close: 04:00PM EST
0.6700 +0.01 (+1.19%)
After hours: 05:22PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 21.62M
Enterprise value 15.53M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)16.31
Price/book (mrq)4.67
Enterprise value/revenue 12.13
Enterprise value/EBITDA -1.78

Trading information

Stock price history

Beta (5Y monthly) 0.97
52-week change 3-78.85%
S&P500 52-week change 322.93%
52-week high 34.8000
52-week low 30.6410
50-day moving average 31.1423
200-day moving average 31.4513

Share statistics

Avg vol (3-month) 3176.5k
Avg vol (10-day) 3339.73k
Shares outstanding 532.66M
Implied shares outstanding 6N/A
Float 829.97M
% held by insiders 13.03%
% held by institutions 111.67%
Shares short (14 Nov 2021) 4424.48k
Short ratio (14 Nov 2021) 42.85
Short % of float (14 Nov 2021) 41.34%
Short % of shares outstanding (14 Nov 2021) 41.30%
Shares short (prior month 14 Oct 2021) 4579.06k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-688.26%

Management effectiveness

Return on assets (ttm)-59.87%
Return on equity (ttm)-640.98%

Income statement

Revenue (ttm)1.28M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-63.69k
EBITDA N/A
Net income avi to common (ttm)-9.13M
Diluted EPS (ttm)-0.2980
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.14M
Total cash per share (mrq)0.34
Total debt (mrq)5.05M
Total debt/equity (mrq)105.78
Current ratio (mrq)8.34
Book value per share (mrq)0.15

Cash flow statement

Operating cash flow (ttm)-12.07M
Levered free cash flow (ttm)-9.04M